Abstract
The interaction between the enzyme transglutaminase 2 (TG2) and fibronectin (FN) is involved in the cellmatrix interactions that regulate cell signaling, adhesion, and migration and play central roles in pathologic conditions, particularly fibrosisandcancer.Aprecisedefinitionof the exact interactiondomainsonboth proteins couldprovide a tool to design novelmolecules with potential therapeutic applications.Although specific residues involved in the interaction within TG2 have been analyzed, little is known regarding the TG2 binding site on FN. This site has been mapped to a large internal 45-kDa protein fragment coincident with the gelatin binding domain (GBD). With the goal of defining the minimal FN interacting domain for TG2, we produced several expression constructs encoding different portions or modules of the GBD and tested their binding and functional properties. The results demonstrate that the I8 module is necessary and sufficient forTG2-binding in vitro, but does not have functional effects on TG2-expressing cells.Modules I7 and I9 increase the strength of the binding and are required for cell adhesion. A 15-kDa fragment encompassing modules I7-9 behaves as the whole 45-kDa GBD and mediates signaling, adhesion, spreading, and migration of TG2+ cells.Thisstudy providesnewinsights into themechanismforTG2binding toFN.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 2327-2342 |
| Numero di pagine | 16 |
| Rivista | FASEB Journal |
| Volume | 33 |
| Numero di pubblicazione | 2 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2019 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
Fingerprint
Entra nei temi di ricerca di 'Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver